RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Gary Gaufo to Radioligand Assay

Back to Details
This is a "connection" page, showing publications Gary Gaufo has written about Radioligand Assay.
Gary Gaufo
Connection Strength
0.009
Radioligand Assay
  1. Xia M, Sreedharan SP, Bolin DR, Gaufo GO, Goetzl EJ. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. J Pharmacol Exp Ther. 1997 May; 281(2):629-33.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support